🔗 Share this article

Texas Attorney General Ken Paxton is suing the manufacturers of acetaminophen, alleging the companies hid alleged dangers that the medication created to pediatric neurological development.

The lawsuit arrives thirty days after Donald Trump publicized an unproven link between consuming Tylenol - also known as paracetamol - during pregnancy and autism spectrum disorder in young ones.

The attorney general is filing suit against Johnson & Johnson, which formerly manufactured the medication, the exclusive pain medication recommended for pregnant women, and Kenvue, which now manufacturers it.

In a official comment, he said they "betrayed America by gaining financially from pain and pushing pills regardless of the potential hazards."

Kenvue states there is no credible evidence tying acetaminophen to autism spectrum disorder.

"These companies lied for decades, deliberately risking numerous people to boost earnings," the attorney general, a Republican, declared.

Kenvue said in a statement that it was "very worried by the spread of false claims on the safety of acetaminophen and the potential impact that could have on the welfare of women and children in America."

On its official site, Kenvue also stated it had "regularly reviewed the relevant science and there is insufficient valid information that indicates a proven link between taking paracetamol and autism."

Groups acting on behalf of doctors and medical practitioners agree.

The American College of Obstetricians and Gynecologists has declared paracetamol - the main ingredient in acetaminophen - is a restricted selection for pregnant women to manage discomfort and fever, which can pose significant medical dangers if not addressed.

"In more than two decades of research on the consumption of paracetamol in gestation, zero credible investigations has definitively established that the consumption of paracetamol in any stage of gestation results in neurological conditions in children," the organization stated.

The lawsuit mentions recent announcements from the previous government in arguing the drug is reportedly hazardous.

In recent weeks, Trump caused concern from medical authorities when he advised pregnant women to "fight like hell" not to take Tylenol when ill.

The US Food and Drug Administration then released a statement that physicians should think about restricting the usage of acetaminophen, while also mentioning that "a direct connection" between the medication and autism in children has not been established.

The Health Department head Kennedy, who oversees the FDA, had promised in April to initiate "comprehensive study program" that would determine the cause of autism in a short period.

But experts warned that identifying a unique factor of autism spectrum disorder - thought by researchers to be the outcome of a complicated interplay of genetic and environmental factors - would be difficult.

Autism is a type of lifelong neurodivergence and disability that affects how people experience and engage with the surroundings, and is diagnosed using medical professional evaluations.

In his court filing, the attorney general - aligned with the former president who is running for federal office - claims Kenvue and J&J "intentionally overlooked and sought to suppress the research" around acetaminophen and autism spectrum disorder.

This legal action seeks to make the corporations "destroy any commercial messaging" that claims Tylenol is reliable for expectant mothers.

The Texas lawsuit mirrors the grievances of a collection of guardians of minors with autism spectrum disorder and ADHD who took legal action against the producers of acetaminophen in recently.

Judicial authorities rejected the lawsuit, declaring research from the plaintiffs' authorities was inconclusive.